Yuyu Telmisartan Plus Tablet 40/12.5 mg

Adult dose

In patients for whom blood pressure is not adequately controlled with monotherapy of telmisartan, take this medication once daily with water, regardless of meals. The combination of Telmisartan/Hydrochlorothiazide 40/12.5 mg can be administered to patients for whom blood pressure is not adequately controlled with 40 mg of telmisartan. The combination of Telmisartan/Hydrochlorothiazide 80/12.5 mg can be administered to patients for whom blood pressure is not adequately controlled with 80 mg of telmisartan.

Child dose

Safety and efficacy in children under 18 years have not been established for this medication.

This drug should not be used during pregnancy, especially in the second and third trimesters, as it can cause severe side effects to the fetus and newborn. Administration should be avoided in individuals with a known allergy to the components of this drug or hypersensitivity to sulfonamide drugs. Do not use this medication in patients with severely impaired liver or kidney function, or those with obstructive biliary disease. Caution should be exercised when administering to the elderly, patients with high potassium levels, weak liver function, or those with heart valve diseases. This drug may cause photosensitivity reactions on the skin, so exposure to sunlight should be avoided, and if any skin abnormalities occur, immediate consultation with a doctor is necessary. Symptoms such as dizziness, hypotension, and electrolyte imbalance may occur during the use of this medication, so caution is needed when such symptoms appear. Due to its blood pressure-lowering effect, caution should be exercised while driving or operating machinery, as drowsiness or dizziness may occur. The risk of side effects may increase when used in combination with other antihypertensive drugs, diuretics, or potassium supplements; thus, consulting a physician or pharmacist is essential. In case of overdose, symptoms such as hypotension, electrolyte disorders, and dehydration may occur, so it is necessary to strictly adhere to the prescribed dosage and administration. Safety for use in children has not been established, so it is recommended not to use this drug in individuals under 18 years of age. This medication is sensitive to moisture, so it should be removed from the packaging just before use and stored out of reach of children.

Serious side effects

Urticaria, severe swelling (edema), angioedema (including fatal outcomes), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), severe fatigue, sudden and severe headache, thunderclap headache, seizures, loss of consciousness

Mild side effects

• Bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia
• sleep disturbances

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, avoid storing the medication in excessively hot or cold places, and it is recommended to keep it at a general indoor temperature between 1 to 30 degrees Celsius.

Appearance

An oval-shaped tablet consisting of two layers, white and pink, which may have pink spots on the white layer.

Package unit

30 tablets (10 tablets/PTPX3)